首页> 中文期刊> 《中国医药导报》 >痰热清注射液治疗小儿急性支气管炎的临床疗效分析

痰热清注射液治疗小儿急性支气管炎的临床疗效分析

         

摘要

目的:探讨痰热清注射液治疗小儿急性支气管炎的临床效果.方法:将116例急性支气管炎随机分为治疗组和对照组各58例,对照组给予常规抗病毒、抗感染、止咳祛痰治疗,治疗组在对照组常规治疗的基础上加用痰热清注射液静脉滴注,剂量为0.5~1.0 ml/(kg·d),比较两组的治疗效果及症状改善情况.结果:治疗1周后,治疗组总有效率为96.55%(56/58),对照组总有效率为77.59%(45/58),两组疗效比较,差异有统计学意义(P<0.05);治疗组平均退热时间、咳嗽消失或明显减轻时间均短于对照组,差异有显著性(P<0.05).结论:在常规治疗的基础上应用痰热清注射液治疗小儿急性支气管炎能迅速缓解症状,缩短疗程,取得较满意的疗效.%Objective: To investigate the clinical efficacy of Tanreqing injection in the treatment of children acute bronchitis. Methods:116 patients with acute bronchitis were randomly divided into control group and treatment group, each 58 cases, the control group was given conventional antivirus, anti-infection, anti-cough expectoranting treatment, the treatment group added Tanreqing injection intravenous drip based on the control group of conventional treatment, dose for 0.5-1.0 ml/(kg·d), therapeutic effect and improvement of symptoms of two groups were compared. Results: After one week's treatment, the total effective rate of the treatment group was 96.55% (56/58), and the control group was 77.59% (45/58), compared with curative effect of the two groups, the difference had statistics significance (P<0.05). The average antifebrile time, cough disappeared or significantly reduced time of the treatment group were shorter than those of control group, there was a significant difference (P<0.05). Conclusion: the conventional treatment added Tanreqing injection in the treatment of children acute bronchitis can rapidly relieve symptoms, shorten the course of treatment, and achieve satisfactory curative effect.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号